These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 12077012)

  • 1. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study.
    Cea G; Bendahan D; Manners D; Hilton-Jones D; Lodi R; Styles P; Taylor DJ
    Brain; 2002 Jul; 125(Pt 7):1635-45. PubMed ID: 12077012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal in vivo skeletal muscle oxidative metabolism in sporadic inclusion body myositis assessed by 31P-magnetic resonance spectroscopy.
    Lodi R; Taylor DJ; Tabrizi SJ; Hilton-Jones D; Squier MV; Seller A; Styles P; Schapira AH
    Brain; 1998 Nov; 121 ( Pt 11)():2119-26. PubMed ID: 9827771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo proton magnetic resonance spectroscopy in polymyositis and dermatomyositis: a preliminary study.
    Chung YL; Smith EC; Williams SC; Wassif WS; Salisbury JR; Simmons A; Howlett DC; Scott DL
    Eur J Med Res; 1997 Nov; 2(11):483-7. PubMed ID: 9385119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calf muscle mitochondrial and glycogenolytic ATP synthesis in patients with claudication due to peripheral vascular disease analysed using 31P magnetic resonance spectroscopy.
    Kemp GJ; Hands LJ; Ramaswami G; Taylor DJ; Nicolaides A; Amato A; Radda GK
    Clin Sci (Lond); 1995 Dec; 89(6):581-90. PubMed ID: 8549076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle.
    Pipinos II; Shepard AD; Anagnostopoulos PV; Katsamouris A; Boska MD
    J Vasc Surg; 2000 May; 31(5):944-52. PubMed ID: 10805885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis by 31P magnetic resonance spectroscopy of abnormal mitochondrial oxidation in skeletal muscle during recovery from exercise.
    Kemp GJ; Taylor DJ; Thompson CH; Hands LJ; Rajagopalan B; Styles P; Radda GK
    NMR Biomed; 1993; 6(5):302-10. PubMed ID: 8268062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of exercise-induced intracellular acidosis on the phosphocreatine recovery kinetics: a 31P MRS study in three muscle groups in humans.
    Layec G; Malucelli E; Le Fur Y; Manners D; Yashiro K; Testa C; Cozzone PJ; Iotti S; Bendahan D
    NMR Biomed; 2013 Nov; 26(11):1403-11. PubMed ID: 23703831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skeletal muscle bioenergetics in myotonic dystrophy.
    Taylor DJ; Kemp GJ; Woods CG; Edwards JH; Radda GK
    J Neurol Sci; 1993 Jun; 116(2):193-200. PubMed ID: 8336166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis.
    Sassani M; Alix JJ; McDermott CJ; Baster K; Hoggard N; Wild JM; Mortiboys HJ; Shaw PJ; Wilkinson ID; Jenkins TM
    Brain; 2020 Dec; 143(12):3603-3618. PubMed ID: 33439988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis.
    Park JH; Olsen NJ; King L; Vital T; Buse R; Kari S; Hernanz-Schulman M; Price RR
    Arthritis Rheum; 1995 Jan; 38(1):68-77. PubMed ID: 7818575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced metabolic efficiency of skeletal muscle energetics in hyperthyroid patients evidenced quantitatively by in vivo phosphorus-31 magnetic resonance spectroscopy.
    Erkintalo M; Bendahan D; Mattéi JP; Fabreguettes C; Vague P; Cozzone PJ
    Metabolism; 1998 Jul; 47(7):769-76. PubMed ID: 9667219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary levels of creatine and other metabolites in the assessment of polymyositis and dermatomyositis.
    Chung YL; Wassif WS; Bell JD; Hurley M; Scott DL
    Rheumatology (Oxford); 2003 Feb; 42(2):298-303. PubMed ID: 12595626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial function and oxygen supply in normal and in chronically ischemic muscle: a combined 31P magnetic resonance spectroscopy and near infrared spectroscopy study in vivo.
    Kemp GJ; Roberts N; Bimson WE; Bakran A; Harris PL; Gilling-Smith GL; Brennan J; Rankin A; Frostick SP
    J Vasc Surg; 2001 Dec; 34(6):1103-10. PubMed ID: 11743568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Altered energy utilization during exercise.
    Newman ED; Kurland RJ
    Arthritis Rheum; 1992 Feb; 35(2):199-203. PubMed ID: 1734909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MRI in the assessment of polymyositis and dermatomyositis.
    Tomasová Studynková J; Charvát F; Jarosová K; Vencovsky J
    Rheumatology (Oxford); 2007 Jul; 46(7):1174-9. PubMed ID: 17500079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic phosphorus-31 magnetic resonance spectroscopy in arterial occlusive disease. Correlation with clinical and angiographic findings and comparison with healthy volunteers.
    Schunk K; Romaneehsen B; Mildenberger P; Kersjes W; Schadmand-Fischer S; Thelen M
    Invest Radiol; 1997 Nov; 32(11):651-9. PubMed ID: 9387051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
    J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical values of FDG PET in polymyositis and dermatomyositis syndromes: imaging of skeletal muscle inflammation.
    Tateyama M; Fujihara K; Misu T; Arai A; Kaneta T; Aoki M
    BMJ Open; 2015 Jan; 5(1):e006763. PubMed ID: 25582454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis.
    Niermann KJ; Olsen NJ; Park JH
    Arthritis Rheum; 2002 Feb; 46(2):475-88. PubMed ID: 11840451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T2 mapping in dermatomyositis/polymyositis and correlation with clinical parameters.
    Ran J; Ji S; Morelli JN; Wu G; Li X
    Clin Radiol; 2018 Dec; 73(12):1057.e13-1057.e18. PubMed ID: 30172348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.